Elan Corp. Plc (ELN) Tuesday advised its shareholders to withdraw any acceptances of Royalty Pharma's offer without delay and not to tender any further acceptances.
Following the outcome of the Elan EGM yesterday, and in accordance with the terms of the Royalty Pharma offer, the Royalty Pharma Offer has now lapsed.
Withdrawal of acceptances of the Royalty Pharma offer will ensure that Elan shareholders are in a position to participate in the benefits of the formal sale process which has now commenced, the firm noted.
Elan's financial advisers contacted Royalty Pharma's financial advisers over the weekend of June 15/16 to invite Royalty Pharma to participate in that process.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.